CORAVAX Trademark

Trademark Overview

On Monday, April 6, 2020, a trademark application was filed for CORAVAX with the United States Patent and Trademark Office. The USPTO has given the CORAVAX trademark a serial number of 88860681. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, March 14, 2025. This trademark is owned by Thomas Jefferson University. The CORAVAX trademark is filed in the Pharmaceutical Products category with the following description:

vaccines; pharmaceutical preparations
coravax

General Information

Serial Number88860681
Word MarkCORAVAX
Filing DateMonday, April 6, 2020
Status641 - NON-FINAL ACTION - MAILED
Status DateFriday, March 14, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and Servicesvaccines; pharmaceutical preparations

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameThomas Jefferson University
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPhiladelphia, PA 19107

Trademark Events

Event DateEvent Description
Thursday, April 9, 2020NEW APPLICATION ENTERED
Monday, April 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, August 5, 2020ASSIGNED TO EXAMINER
Tuesday, August 25, 2020NON-FINAL ACTION WRITTEN
Tuesday, August 25, 2020NON-FINAL ACTION E-MAILED
Tuesday, August 25, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, January 14, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, January 14, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, January 14, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 15, 2021SUSPENSION LETTER WRITTEN
Friday, January 15, 2021LETTER OF SUSPENSION E-MAILED
Friday, January 15, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, July 19, 2021REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Monday, February 14, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Wednesday, March 9, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Wednesday, September 7, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, March 10, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, September 8, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, March 7, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, September 6, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, March 14, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 14, 2025NON-FINAL ACTION E-MAILED
Friday, March 14, 2025NON-FINAL ACTION WRITTEN

Related Keywords

coravax preparations pharmaceutical vaccines